by Lee Seunghyeong
Published 12 Aug.2024 18:57(KST)
Kwangdong Pharmaceutical announced on the 12th that its consolidated operating profit for the second quarter of this year was preliminarily estimated at 5 billion KRW, a 57.7% decrease compared to the same period last year.
Sales increased by 10.0% during the same period to 412.8 billion KRW. Net profit decreased by 81.1% to 1.7 billion KRW.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.